Background Recent data suggests an association between blood hyperviscosity and both
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …

Although COVID-19 begins as a respiratory pneumonia, we are now discovering it causes
an intense inflammatory response accompanied by systemic microangiopathy. In reflecting …

Background and objectives Cytokine release syndrome in COVID‐19 is due to a
pathological inflammatory response of raised cytokines. Removal of these cytokines by …

BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and
globulins, is associated with thrombotic complications, organ failure, and higher mortality in …

At the end of December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared in Wuhan …

Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

We conducted this systematic review and meta‐analysis to evaluate the existing evidence
and to quantitatively synthesise evidence on the impact of therapeutic plasma exchange …

Objective To evaluate the therapeutic use of plasma exchange in COVID-19 patients
compared to controls. Methods A case series of critically ill adult men and non-pregnant …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Purpose We investigated the effect of therapeutic plasma exchange (TPE) on life-
threatening COVID-19; presenting as acute respiratory distress syndrome (ARDS) plus multi …